Patents by Inventor Ulf Nilsson

Ulf Nilsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9212277
    Abstract: A cable comprising a semiconductive layer and an insulation layer with improved DC electrical properties is provided.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: December 15, 2015
    Assignee: BOREALIS AG
    Inventors: Ulf Nilsson, Annika Smedberg, Alfred Campus
  • Patent number: 9198124
    Abstract: A method for performing a selection of a public land mobile network identity in a shared network environment, in which environment at least two public land mobile network identities are available for providing circuit switched based service to user equipment. The method includes at least a step of deter-mining a capability of the user equipment and a step of selecting the public land mobile network identity at least partly on the basis of the capability of the user equipment among the at least two public land mobile network identities. Information on the capability of the user equipment is either received from the user equipment or from a database including capability information on the user equipment. Furthermore, a network element and a system for implementing at least partly the method are described.
    Type: Grant
    Filed: April 3, 2013
    Date of Patent: November 24, 2015
    Assignee: TELIASONERA AB
    Inventors: Anders Dahlen, Ulf Nilsson
  • Publication number: 20150320782
    Abstract: Methods and kits using a pharmaceutical composition for use in inhibiting ocular angiogenesis or fibrosis are provided herein, such that composition includes a pharmaceutically suitable carrier or diluent and an amount of the inhibitor composition effective to inhibit the angiogenesis or the fibrosis by inhibiting expression and/or activity of a galectin protein or a portion thereof.
    Type: Application
    Filed: May 15, 2015
    Publication date: November 12, 2015
    Inventors: Noorjahan Panjwani, Wei-Sheng Chen, Hakon Leffler, Ulf Nilsson
  • Publication number: 20150274764
    Abstract: The present invention relates to a compound of the general formula (I) for pulmonary administration. The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Furthermore the present invention concerns a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject.
    Type: Application
    Filed: October 30, 2013
    Publication date: October 1, 2015
    Applicant: Galecto Biotech AB
    Inventors: Ulf Nilsson, Hakon Leffler, Neil Henderson, Tariq Sethi, Alison MacKinnon
  • Patent number: 9115227
    Abstract: The invention relates to a method for producing a polymer using a chain transfer agents. In particular, the invention relates to a process for polymerizing a polymer in the presence of a mixture of at least two chain transfer agents, which mixture comprises a polar chain transfer agent (polar CTA), and a non-polar (non-polar CTA).
    Type: Grant
    Filed: July 8, 2009
    Date of Patent: August 25, 2015
    Assignee: Borealis AG
    Inventors: Alfred Campus, Markus Huber, Ulf Nilsson, Hermann Schild, Annika Smedberg, Bjorn Voigt
  • Patent number: 9049624
    Abstract: A method where a first type location area of a mobile node is registered to a first mobility management node. A second type location area is determined based on a location of the mobile node. A second type location area of the mobile node is registered to a second mobility management node of a second system. A request to perform user plane bearer establishment through the second system is received. Thereupon, radio measurements associated with at least two candidate cells are obtained from the mobile node. Candidate cells are searched to find at least one cell associated with the second type location area. A cell is selected among the at least one cell, which is indicated to the selected cell to the mobile node. A handover request is provided to the mobile node.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: June 2, 2015
    Assignee: TELIASONERA AB
    Inventors: Anders Dahlén, Ulf Nilsson
  • Patent number: 9005580
    Abstract: Methods for treating renal cancer by administration of certain 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide compounds, especially 3,3?,4,4?-tetrahydroxy-2,2?-bipyridine-N,N?-dioxide (Orellanine), conjugated to an alpha-emitting radionuclide (e.g. Astatine-211) to increase the efficacy of the formulation and/or a large molecule (e.g. a oligomer/polymer such as a PEG or a polysaccharide such as a dextran or a Ficoll®) to reduce the filtration and consequently the renal exposure. Particular administration protocols and dosing regimens, as well as pharmaceutical compositions suitable for use in the treatment methods can be used.
    Type: Grant
    Filed: March 28, 2011
    Date of Patent: April 14, 2015
    Assignee: Oncorena AB
    Inventors: Borje Haraldsson, Ulf Nilsson, Lisa Buvall, Jenny Nystrom
  • Patent number: 8959923
    Abstract: An arrangement for preparation of a fuel for combustion including a burner is provided. The arrangement includes a combustion chamber associated with the burner and in which combustion of a fuel is to take place, as well as means for supplying liquid fuel to the arrangement through an internal passage in the burner for the combustion, solid portions of the burner body being heated by the combustion, wherein the internal passage is located inside the solid portions of the burner body for receiving heat energy evaporating the fuel from these body portions, and that it includes means for conveying vaporized fuel to the combustion chamber to take part in the combustion.
    Type: Grant
    Filed: February 20, 2012
    Date of Patent: February 24, 2015
    Assignee: Siemens Aktiengesellschaft
    Inventors: Ulf Nilsson, Peter Senior
  • Publication number: 20150015273
    Abstract: A method for determining conductivity of cable insulation of a cable including at least one conductor that determines the central axis of the cable and insulation layer surrounding the conductor longitudinally and radially includes steps of retrieving a cable sample from a cable, which sample includes a length of at least one insulation layer and preparing an insulation sample from the cable sample. The insulation sample is prepared from cable sample by cutting a circular layer having a set thickness at desired radius from the central axis of the cable.
    Type: Application
    Filed: September 29, 2014
    Publication date: January 15, 2015
    Inventors: Andreas Farkas, Hossein Ghorbani, Tomas Ahlberg, Johan Andersson, Ulf Nilsson
  • Patent number: 8919126
    Abstract: A device for injecting fuel into a combustion chamber of a gas turbine is provided, having a distribution section to which a first fuel channel, a second fuel channel and an injection channel are coupled. The first fuel channel and the second fuel channel are arranged such that a) fuel is transportable by one of the first fuel channel and the second fuel channel to the distribution section, and b) a first quantity of fuel is transportable by the other one of the first fuel channel and the second fuel channel out of the distribution section. The injection channel is arranged such that a second quantity of fuel is injectable from the distribution section into the combustion chamber. The device further comprises an end cap with a protrusion having the injection channel inside, and extending inside the inner tube.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: December 30, 2014
    Assignee: Siemens Aktiengesellschaft
    Inventor: Ulf Nilsson
  • Publication number: 20140336146
    Abstract: The present invention relates to novel compounds prepared from readily accessible 3-O-propargyl-D-galactopyranoside derivatives and having an effect as i.a., galectin inhibitors, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to ligands in a mammal, wherein said galectin is preferably a galectin-3. The novel compounds are defined by the general formula (I).
    Type: Application
    Filed: January 24, 2013
    Publication date: November 13, 2014
    Applicant: GALECTO BIOTECH AB
    Inventors: Ulf Nilsson, Hakon Leffler, Balaram Mukhopadhyay, Vishal Rajput
  • Publication number: 20140260292
    Abstract: A gas turbine having a combustion chamber with exhaust section through which combustion gas is exhaustable, plenum chamber and compressor are provided. The plenum chamber is coupled to the compressor wherein a first quantity of compressed fluid is injectable therein at a radially inner wall of the plenum chamber. A guide vane section with at least one airfoil is coupled to the exhaust section so combustion gas is flowable against the airfoil. The exhaust section and guide vane section are housed inside the plenum chamber. The airfoil has a first flow chamber where a second quantity of compressed fluid is flowable through the guide vane section from the compressor in the direction from the inner wall to a outer wall of the plenum chamber before being discharged. The second quantity of compressed fluid streamable through the guide vane section is larger than the first quantity of the compressed fluid.
    Type: Application
    Filed: September 4, 2012
    Publication date: September 18, 2014
    Applicant: SIEMENS AKTIENGESELLSCHAFT
    Inventor: Ulf Nilsson
  • Publication number: 20140219788
    Abstract: The present invention relates to a turbine assembly with a basically hollow aerofoil, having at least a cavity with an inner wall and having at least an aperture providing access to the cavity, and at least a first impingement device arrangeable within the cavity. The at least first impingement device is self-locking, resilient and preloadable and has at least one locking element to lock the at least first impingement device in place in the cavity via a force fit between the at least one locking element and the inner wall of the cavity wherein the locking element of the at least first impingement device is embodied as a protrusion extending in an assembled state of the at least first impingement device in the cavity basically perpendicular to a surface of a side wall of the at least first impingement device in a direction towards the inner wall.
    Type: Application
    Filed: September 3, 2012
    Publication date: August 7, 2014
    Applicant: SIEMENS AKTIENGESELLSCHAFT
    Inventor: Ulf Nilsson
  • Publication number: 20140213258
    Abstract: A method for determining a capability of a user equipment. The user equipment is served by a non-shared network in a first place. The non-shared network is configured to transmit a message to the user equipment, the message including information on at least two PLMN identities. The user equipment is configured to deliver a response message from which it is determined if the response message includes information field reserved for at least one PLMN identity in the transmitted message. On a basis of an existence of the information field in the response message it can be determined that the user equipment supports network sharing. In other case it is determined that the user equipment is not supporting network sharing. A network node and a system implementing at least part of the method are also described.
    Type: Application
    Filed: January 24, 2014
    Publication date: July 31, 2014
    Applicant: TELIASONERA AB
    Inventors: Anders DAHLEN, Ulf NILSSON
  • Publication number: 20140190723
    Abstract: Power cable comprising a conductor surrounded by at least one layer comprising a polypropylene, wherein the polypropylene comprises nanosized catalyst fragments being evenly distributed in said polypropylene.
    Type: Application
    Filed: August 29, 2012
    Publication date: July 10, 2014
    Applicant: BOREALIS AG
    Inventors: Torvald Vestberg, Peter Denifl, Per-Ola Hagstrand, Villgot Englund, Ulf Nilsson, Anders Nymark
  • Publication number: 20140171630
    Abstract: Novel synthesis routes for preparation of thiodigalactosides and intermediates are presented. The method includes the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corresponding thiol in situ, which in turn is directly reacted with a 3-azido-galactosyl bromide resulting in the 3,3?-di-azido-thio-di-galactoside before the thiol has a chance to reduce the azido 10 group. Hence, in situ formation of the 3-azido-galactosyl thiol from the thiouronium salt is essential in the synthesis procedure, because any other method that generate the thiol separately results in extensive unwanted azide reduction.
    Type: Application
    Filed: February 20, 2014
    Publication date: June 19, 2014
    Applicant: GALECTO BIOTECH AB
    Inventor: Ulf NILSSON
  • Patent number: 8722763
    Abstract: The present invention relates to a process for preparing a polymer composition by using a masterbatch, as well as a process, wherein said polymer composition is used for preparing an article, preferably a cable. Also a masterbatch, a polymer composition comprising the masterbatch, and an article, preferably a cable, comprising the polymer composition are provided.
    Type: Grant
    Filed: December 21, 2009
    Date of Patent: May 13, 2014
    Assignee: Borealis AG
    Inventors: Annika Smedberg, Philippe Ravera, Ulf Nilsson
  • Publication number: 20140121179
    Abstract: The present invention relates to a compound of the general formula (I): The compound of formula (I) is suitable for treating pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a mammal. Furthermore the present invention concerns a method of monitoring development or progression of pulmonary fibrosis in a human subject, a method of monitoring or predicting exacerbation of symptoms in a human subject with pulmonary fibrosis as well as a method for treatment of pulmonary fibrosis, such as Idiopathic pulmonary fibrosis in a human subject having a galectin-3 level indicative of pulmonary fibrosis or exacerbation of symptoms.
    Type: Application
    Filed: March 15, 2013
    Publication date: May 1, 2014
    Inventors: Neil Henderson, Tariq Sethi, Alison Mackinnon, Hakon Leffler, Ulf Nilsson
  • Patent number: 8697862
    Abstract: Novel synthesis routes for preparation of thiodigalactosides and intermediates are presented. The method includes the use of a 3-azido-galactosyl thiouronium salt derivative, which is activated to the corresponding thiol in situ, which in turn is directly reacted with a 3-azido-galactosyl bromide resulting in the 3,3?-di-azido-thio-di-galactoside before the thiol has a chance to reduce the azido 10 group. Hence, in situ formation of the 3-azido-galactosyl thiol from the thiouronium salt is essential in the synthesis procedure, because any other method that generate the thiol separately results in extensive unwanted azide reduction.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: April 15, 2014
    Assignee: Galecto Biotech AB
    Inventor: Ulf Nilsson
  • Publication number: 20140093732
    Abstract: The present invention relates to a polymer composition, to the use of the composition for producing an electrical device, as well as to a cable surrounded by at least one layer including the polymer composition.
    Type: Application
    Filed: May 3, 2012
    Publication date: April 3, 2014
    Applicant: BOREALIS AG
    Inventors: Johan Andersson, Villgot Englund, Per-Ola Hagstrand, Ulf Nilsson, Annika Smedberg, Thomas Steffl, Johannes Wolfschwenger